Methyl-CpG-binding protein 2 (MeCP2) mutation developed into the Rett syndrome (RTT), and RTT patients had significantly less diversity in gut bacteria community compared with healthy controls (p < 0.01). This evidence concerns the gene MECP2 and Rett syndrome.